| Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi L Brown, JM Wolf, R Prados-Rosales, A Casadevall Nature Reviews Microbiology 13 (10), 620-630, 2015 | 1412 | 2015 |
| Extracellular vesicles produced by the Gram‐positive bacterium Bacillus subtilis are disrupted by the lipopeptide surfactin L Brown, A Kessler, P Cabezas‐Sanchez, JL Luque‐Garcia, ... Molecular microbiology 93 (1), 183-198, 2014 | 174 | 2014 |
| Listeria monocytogenes virulence factors, including listeriolysin O, are secreted in biologically active extracellular vesicles C Coelho, L Brown, M Maryam, R Vij, DFQ Smith, MC Burnet, JE Kyle, ... Journal of Biological Chemistry 294 (4), 1202-1217, 2019 | 138 | 2019 |
| The gut microbiome in depression and potential benefit of prebiotics, probiotics and synbiotics: a systematic review of clinical trials and observational studies SR Alli, I Gorbovskaya, JCW Liu, NJ Kolla, L Brown, DJ Müller International journal of molecular sciences 23 (9), 4494, 2022 | 124 | 2022 |
| Pharmacogenomic testing and depressive symptom remission: a systematic review and meta‐analysis of prospective, controlled clinical trials LC Brown, JD Stanton, K Bharthi, AA Maruf, DJ Müller, CA Bousman Clinical Pharmacology & Therapeutics 112 (6), 1303-1317, 2022 | 78 | 2022 |
| Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria R Prados-Rosales, L Brown, A Casadevall, S Montalvo-Quirós, ... MethodsX 1, 124-129, 2014 | 65 | 2014 |
| Economic burden of depression and associated resource use in Manitoba, Canada JA Tanner, J Hensel, PE Davies, LC Brown, BM Dechairo, BH Mulsant The Canadian Journal of Psychiatry 65 (5), 338-346, 2020 | 62 | 2020 |
| Economic utility: combinatorial pharmacogenomics and medication cost savings for mental health care in a primary care setting LC Brown, RA Lorenz, J Li, BM Dechairo Clinical Therapeutics 39 (3), 592-602. e1, 2017 | 56 | 2017 |
| Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes B Bidinger, R Torres, RG Rossetti, L Brown, R Beltre, S Burstein, JB Lian, ... Clinical immunology 108 (2), 95-102, 2003 | 48 | 2003 |
| The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis L Brown, O Vranjkovic, J Li, K Yu, T Al Habbab, H Johnson, K Brown, ... Pharmacogenomics 21 (8), 559-569, 2020 | 41 | 2020 |
| Bordetella avium antibiotic resistance, novel enrichment culture, and antigenic characterization NM Beach, S Thompson, R Mutnick, L Brown, G Kettig, R Puffenbarger, ... Veterinary microbiology 160 (1-2), 189-196, 2012 | 35 | 2012 |
| Clinical Utilization of Pharmacogenetics in Psychiatry - Perspectives of Pharmacists, Genetic Counselors, Implementation Science, Clinicians, and Industry. L Brown, S Eum, S Haga, J Strawn, H Zierhut Pharmacopsychiatry, 2019 | 29 | 2019 |
| Generation x L Brown, A Haviland, S Morris Contemporary Education 68 (3), 202, 1997 | 25 | 1997 |
| Combinatorial pharmacogenomic testing improves outcomes for older adults with depression BP Forester, SV Parikh, S Weisenbach, O Ajilore, I Vahia, AJ Rothschild, ... The American Journal of Geriatric Psychiatry 28 (9), 933-945, 2020 | 23 | 2020 |
| The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review CA Bousman, A Al Maruf, DF Marques, LC Brown, DJ Müller Psychological Medicine, 1-11, 2023 | 20 | 2023 |
| Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis F Islam, D Hain, D Lewis, R Law, LC Brown, JA Tanner, DJ Müller The pharmacogenomics journal 22 (4), 230-240, 2022 | 19 | 2022 |
| Systematic review and meta-analysis of L-Methylfolate augmentation in depressive disorders A Al Maruf, EA Poweleit, LC Brown, JR Strawn, CA Bousman Pharmacopsychiatry 55 (03), 139-147, 2022 | 14 | 2022 |
| Canadian medication cost savings associated with combinatorial pharmacogenomic guidance for psychiatric medications JA Tanner, LC Brown, K Yu, J Li, BM Dechairo ClinicoEconomics and Outcomes Research, 779-787, 2019 | 14 | 2019 |
| Accelerating medicines partnership® Schizophrenia (AMP® SCZ): Rationale and study design of the largest global prospective cohort study of clinical high risk for psychosis CMJ Wannan, B Nelson, J Addington, K Allott, A Anticevic, C Arango, ... Schizophrenia bulletin 50 (3), 496-512, 2024 | 12 | 2024 |
| Pharmacomicrobiomics of antidepressants in depression: A systematic review LC Brown, WV Bobo, CA Gall, DJ Mueller, CA Bousman Journal of Personalized Medicine 13 (7), 1086, 2023 | 10 | 2023 |
Arturo CasadevallJohns Hopkins School of Public Health在 jhu.edu 的电子邮件经过验证
